While sequencing technology is getting better and faster, it still isn't quite ready to be put to frequent use in the oncology ward, write the Wellcome Trust Center for Human Genetics' Danny Ulahannan and colleagues in a review in the British Journal of Cancer.

In the research setting, they note, there are still challenges in calling low-frequency variants that appear in cancer genomes as well as issues in identifying structural and copy-number variants.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

This Week in Nature

Electric DNA

The Pair of Them

Sequencing to Go

Following the Curve

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.